The use of arginine as an immunostimulator

Abstract From the Canadian patent

The present invention relates to the treatment of an impaired human immune response or to reduction of the severity of degradation of the human immune response by the administration of arginine or ornithine, or a functional analog of arginine or ornithine, or mixtures thereof, to humans suffering from an impaired immune response or at risk of suffering an impaired immune response. Such treatment is provided by enterally administering compositions supplemented with arginine or ornithine or, functional analogs of arginine or ornithine or parenterally administering , amino acid solutions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine to the patient.